We are live on ! Find out more
CLRO icon

ClearOne Inc

9 hedge funds and large institutions have $897K invested in ClearOne Inc in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

2.8% less ownership

Funds ownership: 7.19% → 4.39% (-2.8%)

18% less funds holding

Funds holding: 11 → 9 (-2)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

99% less capital inflows, than outflows

Capital inflows: $4.64K | Capital outflows: $700K

Holders
9
Holders Change
-2
Holders Change %
-18.18%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

CLRO Hedge Fund Activity: Q1 2022 in Review

9 of the 6,364 institutional investors tracked by Wall St. Rank reported a position in ClearOne Inc (CLRO) for Q1 2022, worth a combined $897K — down 57% from $2.08M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of CLRO and 1 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 1 added.

The largest buyer was Tower Research Capital (TRC), adding an estimated $4.16K. The largest seller was Anson Funds Management, exiting entirely with an estimated $240K sold.

  • 9 institutional investors held ClearOne Inc (CLRO) as of Q1 2022, down from 11 in Q4 2021.
  • Funds reported $897K of ClearOne Inc stock for Q1 2022, down 57% quarter-over-quarter.
  • 1 fund opened new ClearOne Inc positions in Q1 2022 and 3 closed out, a net change of -2 holders.
  • The largest ClearOne Inc buyer in Q1 2022 was Tower Research Capital (TRC), an estimated $4.16K added.
  • The largest ClearOne Inc seller in Q1 2022 was Anson Funds Management, an estimated $240K sold.

Based on aggregated 13F filings for Q1 2022.